2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one

2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one Struktur
2514-30-9
CAS-Nr.
2514-30-9
Englisch Name:
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one
Synonyma:
PBIT;CS-1495;PBIT, >=98%;PBIT >=98% (HPLC);JUMONJI HDM INHIBITOR;2-p-Tolyl-1,2-benzisothiazolin-3-one;2-(p-Tolyl)benzo[d]isothiazol-3(2H)-one;2-(4-methylphenyl)-1,2-benzothiazol-3-one;Histone Demethylase,Inhibitor,PBIT,inhibit;1,2-Benzisothiazol-3(2H)-one, 2-(4-methylphenyl)-
CBNumber:
CB92681578
Summenformel:
C14H11NOS
Molgewicht:
241.31
MOL-Datei:
2514-30-9.mol

2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one Eigenschaften

Schmelzpunkt:
136.7-137.1 °C(Solv: benzene (71-43-2); hexane (110-54-3))
Siedepunkt:
418.2±38.0 °C(Predicted)
Dichte
1.297±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
Löslichkeit
DMSO: soluble10mg/mL, clear (warmed)
pka
-0.03±0.20(Predicted)
Aggregatzustand
powder
Farbe
white to beige
Stabilität:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
WGK Germany  3
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" />
Sicherheit
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P270 Bei Gebrauch nicht essen, trinken oder rauchen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P302+P352 BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
P321 Besondere Behandlung
P330 Mund ausspülen.
P332+P313 Bei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
P362 Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.
P501 Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Jumonji AT-rich interactive domain 1 (JARID1) demethylases mediate the removal of methyl groups from trimethylated lysine 4 on histone 3 (H3K4me3). PBIT is a reversible, cell-permeable inhibitor of JARID1 family demethylases (IC50s = 6, 3, 4.9, and 28 μM for JARID1A, JARID1B, JARID1C, and JARID1D, respectively). It does not significantly affect the activity of UTX and JMJD3 demethylases. It increases trimethylation of H3K4 in HeLa cells and blocks the proliferation of tumor cells expressing high levels of JARID1B.

Biochem/physiol Actions

PBIT is a potent inhibitor of JARID1B (KDM5B) histone lysine demethylase that inhibits removal of H3K4me3 in UACC-812 cells. PBIT inhibits proliferation of cells overexpressing JARID1B. PBIT is selective for JARID1 enzymes and does not inhibit demethylases UTX or JMJD3.

Enzyminhibitor

This JARID1 Histone Demethylase inhibitor (FW = 241.31 g/mol; CAS 2514-30-9; Soluble to 100 mM in DMSO), also named 2-(4-methylphenyl)- 1,2-benzisothiazol-3(2H)-one, targets the Jumonji AT-Rich Interactive Domain 1, with respective IC50 values of 3, 4.9 and 6 μM for JARID1B, JARID1A and JARID1C. The enzymes responsible for the demethylation of trimethylated lysine 4 in histone H3 (H3K4me3) are the Jumonji AT-rich interactive domain 1 (JARID1) or lysine demethylase-5 (KDM5) family of lysine demethylases. This family consists of JARID1A (also known as KDM5A or RBP2), JARID1B (also known as KDM5B or PLU1), JARID1C (also known as KDM5C or SMCX), and JARID1D (also known as KDM5D or SMCY) in mammals. Like other JmjC domain-containing demethylases, JARID1 enzymes catalyze histon demethylation in a Fe(II) and α-ketoglutarate (α-KG)-dependent reaction. Oxidative decarboxylation of α-KG results in an unstable hydroxylated methyl-lysine intermediate. Release of the hydroxyl and methyl groups as formaldehyde from this intermediate results in demethylation. JARID1 demethylases have been linked to human diseases such as cancer and X-linked mental retardation. Both JARID1A and JARID1B are potential oncoproteins, and both are overexpressed in a variety of cancers. Increased expression of JARID1A promotes a more stem-like phenotype and enhanced resistance to anticancer agents. PBIT was identified by high-throughput screening (using biotinylated H3K4me3 peptide substrate) of agents that are selective for JARID1 over UTX and JMJD3. PBIT increases levels of methylated H3K4 in JARIDB1-transfected HeLa cells and MCF7 cells. (JARID1A and JARID1B knock-out mice are viable, suggesting that inhibition of JARID1A or JARID1B has minimal effects on normal cells in vivo. ) PBIT also inhibits proliferation of breast cancer cell lines expressing high levels of JARIDB1.

2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 66)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32480 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674;
laboratory@coreychem.com China 30255 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054
trendseenbio@gmail.com China 11681 58
Wuhan Han Sheng New Material Technology Co.,Ltd
+8617798174412
admin01@hsnm.com.cn China 2118 58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
+8619164747840
13119157289@163.com China 2971 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
EnliPharma Technology Co., Ltd 0551-66399836 18955197623
sales@enlipharma.com China 1874 55
AdooQ Bioscience CHINA 025-58849295 18951903616;
info@adooq.cn China 2989 60

2514-30-9()Verwandte Suche:


  • 2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one
  • 2-(4-Methylphenyl)-2,3-dihydrobenzisothiazol-3-one
  • 2-p-Tolyl-1,2-benzisothiazolin-3-one
  • PBIT
  • PBIT, >=98%
  • JUMONJI HDM INHIBITOR
  • CS-1495
  • 2-(4-methylphenyl)-1,2-benzothiazol-3-one
  • 1,2-Benzisothiazol-3(2H)-one, 2-(4-methylphenyl)-
  • PBIT >=98% (HPLC)
  • 2-(p-Tolyl)benzo[d]isothiazol-3(2H)-one
  • Histone Demethylase,Inhibitor,PBIT,inhibit
  • 2514-30-9
Copyright 2019 © ChemicalBook. All rights reserved